Latest Administration News

Mineral Commodities Limited has completed the sale of its Skaland Graphite Project in Norway for USD 8.75 million as part of its voluntary administration process. The transaction marks a significant step in the company’s restructuring efforts.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

Eureka Group Holdings has confirmed its ordinary dividend for the half-year ending December 2025, detailing payment terms including a Dividend Reinvestment Plan price and New Zealand Dollar exchange rate.

Ansell Limited has updated its FY26 interim dividend details, confirming a USD 0.266 per share payout and setting the Dividend Reinvestment Plan price at USD 22.24 per share. The dividend will be paid in US dollars with an Australian dollar equivalent of AUD 0.3768 per share.

Beetaloo Energy has responded to ASX concerns over a delayed disclosure of a director's change in interest, attributing it to an administrative oversight and pledging enhanced compliance measures.

LTR Pharma has finalised recruitment for its Phase II clinical trial of SPONTAN, a rapid-acting intranasal spray for erectile dysfunction, with initial results expected in the second quarter of 2026.

Diablo Resources has significantly increased its Star Range Silver-Antimony Project footprint in Utah by acquiring an additional 646.5 acres adjacent to the South Star Prospect, enhancing geological continuity and exploration potential.

The NSW Department of Planning and Environment has approved a six-year extension for the Dartbrook underground coal mine, pushing its operational horizon to 2033 despite ongoing financial administration challenges.

Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.

ADX Energy has released an updated assessment of its Welchau well in Austria, revealing a significant increase in prospective gas-condensate and light oil resources. The 2024 drilling results highlight promising reservoir conditions and pave the way for further appraisal.

Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.

Eden Innovations Ltd reports a $1.43 million half-year profit, reversing prior losses thanks to a $4.45 million property sale and significant debt reduction, while advancing international commercialisation of its concrete and fuel technologies.